Harbor Advisory Corp Danaher Corp Transaction History

Harbor Advisory Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$185.1 - $233.13 $98,658 - $124,258	-533 Reduced 27.98%	1,372 $317,000
Q2 2023 Aug 03, 2023	SELL	$224.99 - $256.14 $123,744 - $140,877	-550 Reduced 22.4%	1,905 $457,000
Q1 2023 May 04, 2023	BUY	$239.75 - $277.0 $13,426 - $15,512	56 Added 2.33%	2,455 $618,000
Q3 2022 Oct 31, 2022	SELL	$247.06 - $1507.4 $2,717 - $16,581	-11 Reduced 0.46%	2,399 $620,000
Q2 2022 Aug 01, 2022	SELL	$237.11 - $299.66 $59,514 - $75,214	-251 Reduced 9.43%	2,410 $611,000
Q3 2021 Nov 12, 2021	SELL	$272.21 - $332.43 $20,415 - $24,932	-75 Reduced 2.74%	2,661 $810,000
Q1 2021 May 13, 2021	BUY	$212.38 - $245.9 $103,216 - $119,507	486 Added 21.6%	2,736 $616,000
Q4 2020 Feb 16, 2021	BUY	$212.5 - $245.46 $478,125 - $552,285	2,250 New	2,250 $500,000

2,508

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $171B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Harbor Advisory Corp , based on Form 13F filings with the SEC.

Stay updated on Harbor Advisory Corp with notifications on news.